RELIV INTERNATIONAL INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: RELIV INTERNATIONAL INC, 10-Q, 2000-08-14
Next: INVESTORS FIRST STAGED EQUITY L P, 10QSB, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FORM 10-Q
FOR THE  QUARTER  ENDING  MARCH 31,  2000 AND IS  QUALIFIED  IN ITS  ENTIRETY BY
REFRENCE TO SUCH FORM 10-Q.
</LEGEND>


<S>                             <C>
<PERIOD-TYPE>                   6-mos
<FISCAL-YEAR-END>                         DEC-31-2000
<PERIOD-START>                            JAN-01-2000
<PERIOD-END>                              JUN-30-2000
<CASH>                                      1,539,151
<SECURITIES>                                        0
<RECEIVABLES>                               2,753,980
<ALLOWANCES>                                    3,500
<INVENTORY>                                 5,182,162
<CURRENT-ASSETS>                           10,775,150
<PP&E>                                     15,539,170
<DEPRECIATION>                              5,045,174
<TOTAL-ASSETS>                             22,683,797
<CURRENT-LIABILITIES>                      10,031,600
<BONDS>                                     5,019,174
                               0
                                         0
<COMMON>                                    9,082,382
<OTHER-SE>                                 (2,058,702)
<TOTAL-LIABILITY-AND-EQUITY>               22,683,797
<SALES>                                    30,275,182
<TOTAL-REVENUES>                           30,275,182
<CGS>                                      11,852,530
<TOTAL-COSTS>                              29,367,472
<OTHER-EXPENSES>                            9,867,411
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                            300,748
<INCOME-PRETAX>                               556,087
<INCOME-TAX>                                  216,078
<INCOME-CONTINUING>                           340,009
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                  340,009
<EPS-BASIC>                                       .04
<EPS-DILUTED>                                     .03





</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission